Skip to main content

Table 1 Summary of patients with intracranial aneurysms less than 3 years of age (reports in 2021–2022)

From: Quantitative indices for an intracranial aneurysm and subarachnoid hemorrhage in early childhood: a case report

No

Patient ID

Age at onset1

Location, morphology

Etiology

mASPECTS2

Outcome3

Year

Ref

1

Xu-1

1 m

L-cavernous, saccular

Unknown

mRS 0

2021

5

2

De Aguiar-1

1.5 m

R-MCA 10 mm, saccular

Idiopathic

2022

8

3

Clarke-7

2 m

R-MCA 11 mm, saccular

Idiopathic

L

DD, EP

2022

4

4

Clarke-3

3 m

R-MCA 9 mm, fusiform

Idiopathic

L

DD

2022

4

5

Clarke-6

3 m

L-PCA 16 mm, saccular

Idiopathic

DD

2022

4

6

Komuński-1

5 m

R-ICA, saccular

Idiopathic

M

2021

10

7

Clarke-5

6 m

R-MCA 2 mm, saccular

Idiopathic

Hemiparesis

2022

4

8

Clarke-9

6 m

L-MCA 14 mm, saccular

Idiopathic

Hemiparesis, VD

2022

4

9

Clarke-8

7 m

R-ICA 5 mm, saccular

Idiopathic

Hydrocephalus

2022

4

10

Sombo-1

8 m

Proximal basilar 8 mm, fusiform

Post-infectious

L

2021

12

11

Xu-2

9 m

L-MCA, pseudo

Unknown

mRS 2

2021

5

12

Barch-1

10 m

R-MCA, multiple, fusiform

Idiopathic

H

2021

7

13

Saraf-1

11 m

L-MCA, multi-lobular, dissecting

Post-traumatic

H

Hemiplegic gait

2021

11

14

Clarke-10

12 m

R-PCA 10 mm, saccular

Gaucher disease

Hemiparesis

2022

4

15

Xu-3

12 m

L-MCA

Unknown

M

mRS 1

2021

5

16

Clarke-1

1 y 2 m

L-MCA 4 mm, saccular

Idiopathic

Minor spasticity

2022

4

17

Clarke-4

1 y 5 m

R-MCA 18 mm, saccular

Idiopathic

H

Hemiparesis

2022

4

18

Xu-4

1 y 9 m

R-MCA, saccular

Unknown

M

mRS 1

2021

5

19

Xu-5

1 y 10 m

L-cavernous, giant

Unknown

mRS 0

2021

5

20

Clarke-2

1 y 10 m

R-ACA 3 mm

Post-traumatic

No deficit

2022

4

21

Demartini-1

2 y

R-ICA 5 mm, saccular

Post-traumatic

M

Asymptomatic

2021

9

22

Present case

2 y 8 m

R-MCA 21 mm

Idiopathic

L, 2

Died on day 15

  
  1. 1Age represents years (y) and months (m)
  2. 2The mASPECTS scores were estimated and classified into the following three groups according to the presented images: L (low, 0–8), M (moderate, 9–16) and H (high, 17–24). -, no image available
  3. 3Comorbidities and neurological outcomes include epilepsy (EP) and measurements in modified Rankin scale (mRS)
  4. -, No complication or normal development; DD, developmental delay; VD, visual defects; mASPECTS, modified Alberta Stroke Program Early CT Score; Ref, references